These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12089375)

  • 1. Peritubular capillary regression during the progression of experimental obstructive nephropathy.
    Ohashi R; Shimizu A; Masuda Y; Kitamura H; Ishizaki M; Sugisaki Y; Yamanaka N
    J Am Soc Nephrol; 2002 Jul; 13(7):1795-805. PubMed ID: 12089375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferation and remodeling of the peritubular microcirculation after nephron reduction: association with the progression of renal lesions.
    Pillebout E; Burtin M; Yuan HT; Briand P; Woolf AS; Friedlander G; Terzi F
    Am J Pathol; 2001 Aug; 159(2):547-60. PubMed ID: 11485913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local CD34-positive capillaries decrease in mouse models of kidney disease associating with the severity of glomerular and tubulointerstitial lesions.
    Masum MA; Ichii O; Elewa YHA; Nakamura T; Kon Y
    BMC Nephrol; 2017 Sep; 18(1):280. PubMed ID: 28870174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound super-resolution imaging for the assessment of renal allograft dysfunction: A pilot study.
    Hu Y; Lei Y; Yu M; Zhang Y; Huang X; Zhang G; Deng Q
    Heliyon; 2024 Aug; 10(16):e36515. PubMed ID: 39247269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collecting Duct Pro(Renin) Receptor Contributes to Unilateral Ureteral Obstruction-Induced Kidney Injury via Activation of the Intrarenal RAS.
    Luo R; Yang KT; Wang F; Zheng H; Yang T
    Hypertension; 2024 Oct; 81(10):2152-2161. PubMed ID: 39171392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney Fibrosis and Oxidative Stress: From Molecular Pathways to New Pharmacological Opportunities.
    Patera F; Gatticchi L; Cellini B; Chiasserini D; Reboldi G
    Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38275766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The AKI-to-CKD Transition: The Role of Uremic Toxins.
    André C; Bodeau S; Kamel S; Bennis Y; Caillard P
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconfiguration and loss of peritubular capillaries in chronic kidney disease.
    Gaupp C; Schmid B; Tripal P; Edwards A; Daniel C; Zimmermann S; Goppelt-Struebe M; Willam C; Rosen S; Schley G
    Sci Rep; 2023 Nov; 13(1):19660. PubMed ID: 37952029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial Oxidative Metabolism: An Emerging Therapeutic Target to Improve CKD Outcomes.
    Mapuskar KA; Vasquez-Martinez G; Mayoral-Andrade G; Tomanek-Chalkley A; Zepeda-Orozco D; Allen BG
    Biomedicines; 2023 May; 11(6):. PubMed ID: 37371668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet Rich Plasma and Adipose-Derived Mesenchymal Stem Cells Mitigate Methotrexate-Induced Nephrotoxicity in Rat via Nrf2/Pparγ/HO-1 and NF-Κb/Keap1/Caspase-3 Signaling Pathways: Oxidative Stress and Apoptosis Interplay.
    Wani FA; Ibrahim MA; Ameen SH; Farage AE; Ali ZA; Saleh K; Farag MM; Sayeed MU; Alruwaili MAY; Alruwaili AHF; Aljared AZA; Galhom RA
    Toxics; 2023 Apr; 11(5):. PubMed ID: 37235213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal Microcirculation Injury as the Main Cause of Ischemic Acute Kidney Injury Development.
    Kwiatkowska E; Kwiatkowski S; Dziedziejko V; Tomasiewicz I; Domański L
    Biology (Basel); 2023 Feb; 12(2):. PubMed ID: 36829602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tubular epithelial cells-derived small extracellular vesicle-VEGF-A promotes peritubular capillary repair in ischemic kidney injury.
    Zhong X; Tang TT; Shen AR; Cao JY; Jing J; Wang C; Zhu XX; Wen Y; Li ZL; Wang B; Qin SF; Liu BC; Lv LL
    NPJ Regen Med; 2022 Dec; 7(1):73. PubMed ID: 36528739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro- and anti-fibrotic effects of vascular endothelial growth factor in chronic kidney diseases.
    Miao C; Zhu X; Wei X; Long M; Jiang L; Li C; Jin D; Du Y
    Ren Fail; 2022 Dec; 44(1):881-892. PubMed ID: 35618410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hypoxia on bone metabolism and anemia in patients with chronic kidney disease.
    Kan C; Lu X; Zhang R
    World J Clin Cases; 2021 Dec; 9(34):10616-10625. PubMed ID: 35004993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of transforming growth factor-β-induced kidney fibrosis by leucine-rich ⍺-2 glycoprotein-1.
    Hong Q; Cai H; Zhang L; Li Z; Zhong F; Ni Z; Cai G; Chen XM; He JC; Lee K
    Kidney Int; 2022 Feb; 101(2):299-314. PubMed ID: 34774561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between urinary VEGFA and renal pathology of IgA nephropathy patients.
    Feng S; Huang N; Xue M; Zhang P; Zhong Z; Guo Q; Li Z
    J Clin Lab Anal; 2021 Sep; 35(10):e23995. PubMed ID: 34498313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The renal microcirculation in chronic kidney disease: novel diagnostic methods and therapeutic perspectives.
    Li S; Wang F; Sun D
    Cell Biosci; 2021 May; 11(1):90. PubMed ID: 34001267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast heterogeneity and tertiary lymphoid tissues in the kidney.
    Arai H; Sato Y; Yanagita M
    Immunol Rev; 2021 Jul; 302(1):196-210. PubMed ID: 33951198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute kidney injury leading to CKD is associated with a persistence of metabolic dysfunction and hypertriglyceridemia.
    Harzandi A; Lee S; Bidkhori G; Saha S; Hendry BM; Mardinoglu A; Shoaie S; Sharpe CC
    iScience; 2021 Feb; 24(2):102046. PubMed ID: 33554059
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.